3-(2,5-Dimethyl-1h-pyrrol-1-yl)propanoic acid, 97%, 10g

(3-Bromopyridin-2-yl)methanamine hydrochloride, 95.0%, 1g

4-Amino-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one hydrate, 95.0%, 1g

4-[(3R)-Piperidin-3-yl]morpholin-3-one hydrochloride, 1g

5-BROMO-1-METHYL-3-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95.0%, 250mg

1-Piperidineethanol>98.0%(GC)500g

Cyclohexane D 12, 99.5 at%D, 5 ml, glass packaging

(1r)-1-(2-Chloro-5-fluorophenyl)ethan-1-ol, 98%, 250mg

Ethyl 5-(4-fluorophenyl)-5-oxovalerate, 97.0%, 5g

cis-tetrahydro-1H-thieno[3,4-d]imidazol-2(3H)-one 5,5-dioxide, 95.0%, 5g

Ethyl 2-amino-4-chlorobenzoate, 98%, 100g

Sodium 2-hydroxy-2-(4-hydroxyphenyl)acetate, 95.0%, 250mg

4-Bromoresorcinol>98.0%(GC)(T)25g